See also:


The Leukemia & Lymphoma Society (LLS)

Reach out to The Leukemia & Lymphoma Society’s Information Specialists for the latest information on leukemia, lymphoma and myeloma and for support. Call 1.800.955.4572 or email 

Contact information:

3 International Drive, Suite 200
Rye Brook , NY 10573
(914) 949-5213


Clinical Trial MythBusters: What Is the Value of Diversity in Clinical Trials?

Is diversity, gender, age and ethnicity important in clinical trials? Mel Mann, a 20+ year CML survivor and a a highly respected leader in the field of clinical oncology weigh in.


How Can Your Data Sharing Improve Cancer Treatment?

How can patients become actively involved in improving cancer care for all with just a few clicks? Can your electronic medical record be used to drive research forward? Find out now from CLL survivor and patient advocate, Larry Saltzman.


What Are the Side Effect Profiles for Modern AML Treatments?

What potential side effects can AML patients expect from powerful new therapies? Expert, Dr. Ross Levine explains.


Chemo vs. Transplants: What Is the Purpose and Value of Each AML Treatment Method?

There are several treatment methods used for AML patients, but which one is right for you? AML expert Dr. Gwen Nichols gives information on procedure, purpose and value to help patients find the best approach.


How Likely Is It for a Patient's Myelofibrosis or MDS to Transform Into AML?

What percentage of people with MDS or an MPN transform into AML? Our expert panel explains the signs to look for and what tests are done for patient risk assessment.


When Should AML Patients Consider a Splenectomy?

AML expert Dr. Ross Levine explains why and when AML patients should consider getting a splenectomy. Tune in to learn more about AML treatment options.


AML Patient Insight: Resources to Consider to Help Reach Treatment Goals

How can AML patients establish a good foundation with their health care team and get the most out of doctor visits? Watch now to hear from our expert panel valuable tools for patients to use on their treatment journey.


Navigating AML Clinical Trials

AML expert Dr. Gwen Nichols discusses why clinical trials may be the best route for patients who are not responding to the standard of care. Watch now to find out more.


CAR T-Cell Therapy’s Role in AML Treatment

Can AML patients benefit from CAR T-cell therapy? Which patients are a good candidate for this type of treatment? Watch now to hear our ASH 2017 panel of AML experts discuss the latest research.


Showing 9 of 28 programs
Join Our Community Register for Events Read Our Latest Blog

Page last updated on March 13, 2018